Wiesehöfer, M.; Czyrnik, E.D.; Spahn, M.; Ting, S.; Reis, H.; Dankert, J.T.; Wennemuth, G.
Increased Expression of AKT3 in Neuroendocrine Differentiated Prostate Cancer Cells Alters the Response Towards Anti-Androgen Treatment. Cancers 2021, 13, 578.
https://doi.org/10.3390/cancers13030578
AMA Style
Wiesehöfer M, Czyrnik ED, Spahn M, Ting S, Reis H, Dankert JT, Wennemuth G.
Increased Expression of AKT3 in Neuroendocrine Differentiated Prostate Cancer Cells Alters the Response Towards Anti-Androgen Treatment. Cancers. 2021; 13(3):578.
https://doi.org/10.3390/cancers13030578
Chicago/Turabian Style
Wiesehöfer, Marc, Elena Dilara Czyrnik, Martin Spahn, Saskia Ting, Henning Reis, Jaroslaw Thomas Dankert, and Gunther Wennemuth.
2021. "Increased Expression of AKT3 in Neuroendocrine Differentiated Prostate Cancer Cells Alters the Response Towards Anti-Androgen Treatment" Cancers 13, no. 3: 578.
https://doi.org/10.3390/cancers13030578
APA Style
Wiesehöfer, M., Czyrnik, E. D., Spahn, M., Ting, S., Reis, H., Dankert, J. T., & Wennemuth, G.
(2021). Increased Expression of AKT3 in Neuroendocrine Differentiated Prostate Cancer Cells Alters the Response Towards Anti-Androgen Treatment. Cancers, 13(3), 578.
https://doi.org/10.3390/cancers13030578